Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial-Reference-Cited by-同舟云学术

Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial

Published:2017-02 Issue:1 Volume:39 Page:21-28
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Billing Heiko,Höcker Britta,Fichtner Alexander,van Damme-Lombaerts Rita,Friman Styrbjorn,Jaray Jenö,Vondrak Karel,Sarvary Eniko,Dello Strologo Luca,Oellerich Michael,von Ahsen Nicolas,Tönshoff Burkhard

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference34 articles.

1. Assuring the proper analytical performance of measurement procedures for immunosuppressive drug concentrations in clinical practice: recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee;Seger;Ther Drug Monit.,2016

2. Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: age dependency and pharmacological interaction with steroids;Ferraris;Pediatr Transpl.,2011

3. Developmental pharmacology—drug disposition, action, and therapy in infants and children;Kearns;N Engl J Med.,2003

4. Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients;Kuypers;Ther Drug Monit.,2010

5. Optimization of initial tacrolimus dose using pharmacogenetic testing;Thervet;Clin Pharmacol Ther.,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualized dosing parameters for tacrolimus in the presence of voriconazole: a real-world PopPK study;Frontiers in Pharmacology;2024-09-10

2. Association between CYP3A5 Gene Polymorphism and Post-Transplant Acute Immune Rejection in Renal Transplant Recipients Receiving Tacrolimus Therapy: A Correlation Study;Archivos Españoles de Urología;2024

3. Effects of CYP3A4*22 polymorphism on trough concentration of tacrolimus in kidney transplantation: a systematic review and meta-analysis;Frontiers in Pharmacology;2023-07-26

4. Tacrolimus pharmacokinetics are influenced by CYP3A5, age, and concomitant fluconazole in pediatric kidney transplant patients;Clinical and Translational Science;2023-06-26

5. Predictive Capacity of Population Pharmacokinetic Models for the Tacrolimus Dose Requirements of Pediatric Solid Organ Transplant Recipients;Therapeutic Drug Monitoring;2023-02